Aclaris Therapeutics Ownership | Who Owns Aclaris Therapeutics?


OverviewForecastRevenueFinancialsChart

Aclaris Therapeutics Ownership Summary


Aclaris Therapeutics is owned by 92.76% institutional investors, 2.18% insiders, and 5.05% retail investors. Ra capital management is the largest institutional shareholder, holding 9.88% of ACRS shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 3.04% of its assets in Aclaris Therapeutics shares.

ACRS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAclaris Therapeutics92.76%2.18%5.05%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustryBiotech Stocks 380.48%11.73%-292.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management12.72M9.88%$67.30M
Bml capital management11.97M9.30%$63.35M
Blackrock funding, inc. /de10.04M7.79%$53.10M
Deep track capital, lp9.35M7.25%$49.44M
Vanguard group6.50M5.30%$19.57M
Vivo capital6.69M5.20%$35.41M
Vanguard capital management5.82M4.52%$30.78M
Frazier life sciences management4.93M3.82%$26.06M
Rock springs capital management lp4.33M3.36%$22.91M
Adage capital partners gp4.07M3.16%$21.54M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management11.97M35.98%$63.35M
Aldebaran capital936.73K3.72%$4.96M
Vivo capital6.69M3.23%$35.41M
Decheng capital4.04M2.92%$21.38M
Palo alto investors lp1.61M1.18%$8.54M
Rock springs capital management lp4.33M1.12%$22.91M
Silverarc capital management1.95M1.07%$10.30M
Three bridge wealth advisors714.82K0.95%$3.78M
Verdad advisers, lp175.27K0.89%$927.19K
Superstring capital management lp257.68K0.86%$1.36M

Top Buyers

HolderShares% AssetsChange
Ra capital management12.72M0.58%5.92M
Blackrock funding, inc. /de10.04M0.00%2.63M
Silverarc capital management1.95M1.07%1.95M
State street3.26M0.00%1.25M
Panagora asset management1.36M0.02%853.86K

Top Sellers

HolderShares% AssetsChange
Blackrock2.03M0.00%-3.17M
Janus henderson group---2.80M
Morgan stanley134.12K--2.61M
Samsara biocapital---2.39M
Bml capital management11.97M35.98%-2.27M

New Positions

HolderShares% AssetsChangeValue
Silverarc capital management1.95M1.07%1.95M$10.30M
Orbimed advisors421.50K0.04%421.50K$2.23M
Tfg asset management gp400.00K0.33%400.00K$2.12M
Sixth street partners management company346.06K0.00%346.06K$1.83M
Atom investors lp148.85K0.07%148.85K$787.44K

Sold Out

HolderChange
Mai capital management-1.00
Nelson, van denburg & campbell wealth management group-14.00
Root financial partners-27.00
Innealta capital-56.00
Cornerstone planning group-580.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202615510.71%119,486,6189.91%921.30%9528.38%32-20.00%
Mar 31, 2026122-0.81%87,304,5574.26%711.53%6717.54%32-21.95%
Dec 31, 202524-76.70%24,077,074-71.90%190.40%12-72.09%5-87.18%
Sep 30, 202528-68.89%24,422,115-71.00%190.42%8-84.62%11-54.17%
Jun 30, 202595-12.04%91,849,9067.52%741.54%56-9.68%25-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Morn Total Stk Mkt Idx Investor4.24M3.04%598.70K
Vanguard Total Stock Mkt Idx Inv4.24M3.04%598.70K
Vanguard MStar Total Stk Mkt Idx Invest4.24M2.88%-
iShares Russell 2000 ETF3.03M2.06%-53.76K
Vanguard US Total Market Shares ETF2.12M1.96%-
Vanguard Institutional Extnd Mkt Idx Tr1.45M0.99%2.93K
Xtrackers S&P 500 Swap ETF 1C916.55K0.76%-6.76K
SQUAD Aguja Opportunities I500.00K0.70%-
Fidelity Small Cap Index911.89K0.65%3.91K
iShares Russell 2000 Growth ETF937.47K0.64%-8.59K

Recent Insider Transactions


DateNameRoleActivityValue
Apr 23, 2026Leonard Braden Michael-Sell$1.36M
Nov 19, 2024Mehra Anand-Buy$1.50M
Aug 05, 2024Leonard Braden Michael-Buy$256.36K
Aug 02, 2024Leonard Braden Michael-Buy$216.40K
Jul 30, 2024Leonard Braden Michael-Buy$226.37K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--

ACRS Ownership FAQ


Who Owns Aclaris Therapeutics?

Aclaris Therapeutics shareholders are primarily institutional investors at 92.76%, followed by 2.18% insiders and 5.06% retail investors. The average institutional ownership in Aclaris Therapeutics's industry, Biotech Stocks , is 380.48%, which Aclaris Therapeutics falls below.

Who owns the most shares of Aclaris Therapeutics?

Aclaris Therapeutics’s largest shareholders are Ra capital management (12.72M shares, 9.88%), Bml capital management (11.98M shares, 9.30%), and Blackrock funding, inc. /de (10.04M shares, 7.79%). Together, they hold 26.97% of Aclaris Therapeutics’s total shares outstanding.

Does Blackrock own Aclaris Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aclaris Therapeutics.

Who is Aclaris Therapeutics’s biggest shareholder by percentage of total assets invested?

Bml capital management is Aclaris Therapeutics’s biggest shareholder by percentage of total assets invested, with 35.98% of its assets in 11.98M Aclaris Therapeutics shares, valued at 63.35M$.

Who is the top mutual fund holder of Aclaris Therapeutics shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of Aclaris Therapeutics shares, with 3.04% of its total shares outstanding invested in 4.24M Aclaris Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools